Cargando…
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779264/ https://www.ncbi.nlm.nih.gov/pubmed/33408029 http://dx.doi.org/10.1016/j.ijantimicag.2020.106239 |
| _version_ | 1783631297291223040 |
|---|---|
| author | Gautret, Philippe Hoang, Van Thuan Lagier, Jean-Christophe Raoult, Didier |
| author_facet | Gautret, Philippe Hoang, Van Thuan Lagier, Jean-Christophe Raoult, Didier |
| author_sort | Gautret, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7779264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd and International Society of Antimicrobial Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77792642021-01-04 Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes Gautret, Philippe Hoang, Van Thuan Lagier, Jean-Christophe Raoult, Didier Int J Antimicrob Agents Letter to the Editor Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021-01 2021-01-04 /pmc/articles/PMC7779264/ /pubmed/33408029 http://dx.doi.org/10.1016/j.ijantimicag.2020.106239 Text en © 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gautret, Philippe Hoang, Van Thuan Lagier, Jean-Christophe Raoult, Didier Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title_full | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title_fullStr | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title_full_unstemmed | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title_short | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| title_sort | effect of hydroxychloroquine and azithromycin as a treatment of covid-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779264/ https://www.ncbi.nlm.nih.gov/pubmed/33408029 http://dx.doi.org/10.1016/j.ijantimicag.2020.106239 |
| work_keys_str_mv | AT gautretphilippe effectofhydroxychloroquineandazithromycinasatreatmentofcovid19resultsofanopenlabelnonrandomizedclinicaltrialanupdatewithanintentiontotreatanalysisandclinicaloutcomes AT hoangvanthuan effectofhydroxychloroquineandazithromycinasatreatmentofcovid19resultsofanopenlabelnonrandomizedclinicaltrialanupdatewithanintentiontotreatanalysisandclinicaloutcomes AT lagierjeanchristophe effectofhydroxychloroquineandazithromycinasatreatmentofcovid19resultsofanopenlabelnonrandomizedclinicaltrialanupdatewithanintentiontotreatanalysisandclinicaloutcomes AT raoultdidier effectofhydroxychloroquineandazithromycinasatreatmentofcovid19resultsofanopenlabelnonrandomizedclinicaltrialanupdatewithanintentiontotreatanalysisandclinicaloutcomes |